Ingevity Corp Stock
Ingevity Corp shows a slight decrease today, losing -€0.450 (-0.790%) compared to yesterday.
Our community is currently high on Ingevity Corp with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 58 € shows a slightly positive potential of 2.84% compared to the current price of 56.4 € for Ingevity Corp.
Pros and Cons of Ingevity Corp in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ingevity Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ingevity Corp | -0.790% | 1.348% | 10.372% | 33.144% | 12.890% | - | - |
| PTT Global Chemical -fgn- | - | -5.344% | 14.815% | 5.085% | 15.888% | -55.714% | -62.874% |
| PTT Global Chemical -nvdr- | - | -5.882% | 15.315% | 8.475% | 15.315% | -52.941% | -61.905% |
| Barito Pacific Tbk PT | 9.820% | -27.236% | -42.258% | 135.526% | -42.628% | 35.606% | 68.868% |
Comments
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity Corporation (NYSE: NGVT) had its price target raised by analysts at BMO Capital Markets from $56.00 to $62.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NGVT provided by MarketBeat
News
Ingevity (NGVT) Q2 EPS Jumps 38%
Ingevity (NYSE:NGVT), a specialty chemicals and materials company known for transforming renewable resources into high-performance products, released its results for Q2 2025 on August 4, 2025. The
